NIGHT PAROXYSTIC HEMOGLOBINURIA
Keywords:
Paroxysmal nocturnal hemoglobinuria, Microangiopathic hemolytic anemiaAbstract
Paroxysmal nocturnal hemoglobinuria is a rare acquired chronic hemolytic anemia, which affects both sexes with equal frequency. It occurs at any age and more frequently in Southeast Asian countries. It is the result of non malignant clonal expansion of hematopoietic progenitor cells. It is characterized by intravascular hemolytic anemia, recurrent thrombosis and a variable component of bone marrow failure. It is associated with other hematologic disorders such as aplastic anemia and myelodysplastic syndrome. Flow cytometry is the method of choice for diagnosis. Eculizumab and allogeneic bone marrow transplantation is the only effective therapies.
References
2. Brodsky, R. (2008). Narrative review: Paroxysmal nocturnal hemoglobinuria: the physiology of complementrelated hemolytic anemia. Ann. Intern. Med, 148, 587–595.
3. Brodsky, R. (2014). Paroxysmal nocturnal hemoglobinuria. Blood, 124, 2804.
4. Brodsky, R. (2009). How I treat paroxysmal nocturnal hemoglobinuria. Blood, 113, 6522–7.
5. Hernández, P., Almeida, J. & Orfao, A. (2008). Hemoglobinuria paroxística nocturna. Med Clin (Barc), 131, 617–30.
6. Hernández, P., Almeida, J., Acevedo, M., Sánchez, M., Alberca, I., Vidriales, B., et al. (2008). Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria. Transfusion, 48, 1403–14.
7. Hill A, Kelly R, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(25):4985- 4996.
8. Hillmen, P., Muus, P., Röth, A., et al. (2013). Long-term safety and efficacy of sustain edeculizumab treatment in patients with paroxismal nocturnal haemoglobinuria. Br J Haematol, 162(1), 62-73.
9. Hillmen, P., Young, N., Schubert, J., Brodsky, A., Socié, G., Muus, P., et al. (2006). The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med, 355, 1233–43.
10. Hoekstra, J., et al. (2009, Oct). Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort study. J Hepatol., 51(4), 696-706.
11. Moyo, V., Mukhina, G., Garrett, E. & Brodsky, R. (2004). Natural history of paroxismal nocturnal
haemoglobinuria using modern diagnostic assays. Br J Haematol, 126(1), 133-138.
12. Rother, R., Bell, L., Hillmen, P. y Gladwin, M. (2005). The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA, 293(13), 1653-1662.
13. Sánchez, E., et al. (2001). Hemoglobinuria paroxística nocturna. Novedades patogénicas y terapéuticas. An. Med. Interna (Madrid), 18, 8, 435-439.
14. Urbano, A., et al. (2011). Diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. MedClin (Barc), 136(3), 121–127.
15. Van Bijnen, S., Østerud, B., Barteling, W., Verbeek, K., Willemsen, M., Van Heerde, W. & Muus, P. (2015, Aug). Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab. Thromb Res, 136(2), 274-81.
16. Vega, S., et al. (2006). Estudio ultraestructural de las plaquetas de pacientes con hemoglobinuria paroxística nocturna. Rev Invest Clin, 58 (5), 475-486.
Downloads
Published
Issue
Section
License
The intellectual property of accepted works belongs to their authors, however access to them is totally open and free, so they can be reproduced totally or partially with the only limitation of recognizing the authorship and the source of publication (Revista Medicina Legal de Costa Rica), as long as said exploitation does not have commercial character.
